T. Rowe Price Associates’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-78,500
| Closed | -$67K | – | 3053 |
|
|
2024
Q3 | $67K | Hold |
78,500
| – | – | ﹤0.01% | 2889 |
|
|
2024
Q2 | $52K | Hold |
78,500
| – | – | ﹤0.01% | 2849 |
|
|
2024
Q1 | $103K | Hold |
78,500
| – | – | ﹤0.01% | 2776 |
|
|
2023
Q4 | $45K | Hold |
78,500
| – | – | ﹤0.01% | 2822 |
|
|
2023
Q3 | $60K | Hold |
78,500
| – | – | ﹤0.01% | 2748 |
|
|
2023
Q2 | $58K | Sell |
78,500
-23,480
| -23% | -$17.3K | ﹤0.01% | 2781 |
|
|
2023
Q1 | $78K | Buy |
101,980
+22,500
| +28% | +$17.2K | ﹤0.01% | 2729 |
|
|
2022
Q4 | $76K | Buy |
79,480
+4,176
| +6% | +$3.99K | ﹤0.01% | 2761 |
|
|
2022
Q3 | $165K | Sell |
75,304
-88,114
| -54% | -$193K | ﹤0.01% | 2603 |
|
|
2022
Q2 | $572K | Buy |
163,418
+84,700
| +108% | +$296K | ﹤0.01% | 2161 |
|
|
2022
Q1 | $397K | Buy |
78,718
+11,321
| +17% | +$57.1K | ﹤0.01% | 2433 |
|
|
2021
Q4 | $423K | Sell |
67,397
-10,637
| -14% | -$66.8K | ﹤0.01% | 2463 |
|
|
2021
Q3 | $620K | Sell |
78,034
-16,600
| -18% | -$132K | ﹤0.01% | 2268 |
|
|
2021
Q2 | $709K | Buy |
94,634
+12,090
| +15% | +$90.6K | ﹤0.01% | 2208 |
|
|
2021
Q1 | $499K | Sell |
82,544
-1,135,953
| -93% | -$6.87M | ﹤0.01% | 2362 |
|
|
2020
Q4 | $6.96M | Buy |
1,218,497
+493,154
| +68% | +$2.82M | ﹤0.01% | 1395 |
|
|
2020
Q3 | $4.82M | Buy |
+725,343
| New | +$4.82M | ﹤0.01% | 1407 |
|